The Pfizer Building on Flushing Avenue in Clinton Hill is one of the marquee office-to-residential conversions in Brooklyn, and it's now a cautionary tale for anyone underwriting one. A construction mishap during the conversion has become a case study in how insurers and courts are treating the risk on these jobs, according to Insurance Journal, which first reported on the underwriting and litigation lessons emerging from the project.

Conversions carry a specific kind of risk that ground-up work doesn't: you're building inside a structure whose bones, systems, and unknowns were designed for a different use entirely. A crew opening walls to run new plumbing or add windows for residential light and air can hit a structural surprise that a from-scratch job never would. That's exactly the kind of exposure insurers are now pricing harder into wrap-up policies on conversion work.

For New York contractors chasing the office-to-resi wave — and there's a long pipeline of it, from Midtown towers to Brooklyn industrial buildings — this is the fine print that matters more than the glossy renderings. A conversion job that looks like a straightforward gut-and-rebuild on paper can turn into a change-order and claims nightmare once real conditions show up behind the walls. Insurers are responding by tightening what they'll cover and how they price it, and GCs bidding conversion work should expect more scrutiny on their safety and quality-control programs before a carrier signs off on a CCIP or OCIP.

What to do now: any GC or sub pricing an office or industrial conversion in NYC should ask their broker directly how carriers are treating this class of risk post-Pfizer Building, and should build contingency into the bid for the unknowns that don't show up until demo starts. The full underwriting analysis is available from Insurance Journal.